You are here
A New Class of Non-Opioid Analgesics for Use in Chronic Pain Management
Award Information
Agency: Department of Defense
Branch: Defense Health Agency
Contract: W81XWH-17-C-0206
Agency Tracking Number: H2-0224
Amount:
$999,830.00
Phase:
Phase II
Program:
SBIR
Solicitation Topic Code:
Non-DOD
Solicitation Number:
2017.0
Timeline
Solicitation Year:
2017
Award Year:
2017
Award Start Date (Proposal Award Date):
2017-09-25
Award End Date (Contract End Date):
2019-02-24
Small Business Information
10835 Road to the Cure, Suite 205
San Diego, CA
92121
United States
DUNS:
079175579
HUBZone Owned:
No
Woman Owned:
No
Socially and Economically Disadvantaged:
No
Principal Investigator
Name: Kevin Bunker
Title: Chief Scientific Officer
Phone: (858) 263-4333
Email: kbunker@kalyrapharma.com
Title: Chief Scientific Officer
Phone: (858) 263-4333
Email: kbunker@kalyrapharma.com
Business Contact
Name: Kevin Bunker
Phone: (858) 263-4333
Email: kevin@kalyrapharma.com
Phone: (858) 263-4333
Email: kevin@kalyrapharma.com
Research Institution
N/A
Abstract
There has been considerable interest in the development of alternative therapies for pain management that are neither opioid nor non-steroidal anti-inflammatory drugs (NSAIDs). Kalyra Pharmaceuticals has demonstrated that acetaminophen, also known as APAP
* Information listed above is at the time of submission. *
